Search Results 91-100 of 9674 for cannabis

  1. An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes - Mayo Clinic

    Patient is unwilling to abstain from using recreational or medicinal cannabis, or synthetic cannabinoid-based medications (including Sativex) during the study.

  2. Heart attack prevention: Should I avoid secondhand smoke? - Mayo Clinic

    This condition is called endothelial dysfunction. It's associated with many forms of cardiovascular disease. Chemicals in secondhand smoke also irritate the ...

  3. Mayo Clinic Q & A- Dr. Stacy D’Andre - Medical Oncology

    We help people with cannabis counseling, so we do a lot of that to help with symptom management, and if patients have indications we can certify them for ...

  4. A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney stones - Mayo Clinic

    About this study. The purpose of this study is to determine if CBD oil has any effect on decreasing postoperative pain control following ureteroscopy for ...

  5. Publications - Christopher S. Wie, M.D. - Mayo Clinic

    Cannabis for the Treatment of Fibromyalgia: A Systematic Review. Biomedicines. 2023 Jun 2; 11 (6) Epub 2023 June 02. View PubMed; Sowder T, Sayed D, Concannon ...

  6. Midazolam (nasal route) - Mayo Clinic

    Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Carisoprodol; Ceritinib; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Chlorzoxazone ...

  7. A Study to Investigate the Effectiveness and Safety of Cannabidiol in Children and Young Adults with Dravet Syndrome - Mayo Clinic

    Currently or in the past used recreational or medicinal cannabis, or synthetic cannabinoid based medications (including Sativex®) within the three months ...

  8. An Extension Study to Assess the Safety of the Use of Cannabidiol in Children and Young Adults with Dravet or Lennox-Gastaut Syndromes - Mayo Clinic

    Is currently using recreational or medicinal cannabis, or synthetic cannabinoid based medications (including Sativex®) other than the investigational ...

  9. 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression - Mayo Clinic

    Positive toxicology screen for cannabis and a cannabis use disorder by structured clinical interview for DSM-IV-TR. Participants who use cannabis for ...

  10. A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) - Mayo Clinic

    Participant is currently using or has in the past used recreational or medicinal cannabis, or cannabinoid-based medications, within the 3 months prior to ...